Clinical Trial Update: SOX as Adjuvant Chemotherapy for Resectable Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating the SOX regimen (S-1 plus oxaliplatin) as adjuvant chemotherapy for resectable gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Gastric Cancer | Phase 1, Phase 2 | Status: UNKNOWN